Announcements Trials
Browse Landscape

Phase

Phase 2 54Phase NA 41Phase 1 18Phase 3 13Phase EARLY_PHASE1 9Phase 1/2 8Phase 4 3Phase 2/3 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Neoplasm Metastasis 2Breast Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Osteoradionecrosis 1Obesity 1Neoplasms 1Mouth Neoplasms 1Metastasising Cancer of Unknown Primary 1Invasive Breast Cancer 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Digestive System Neuroendocrine Tumor G1 1Coronary Artery Disease 1Colorectal Neoplasms 1Castration Resistant Prostate Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Zoledronic Acid 14Leuprolide 9bicalutamide 6Triptorelin Pamoate 6Goserelin 6luprolide acetate gel depot 5enzalutamide 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5Dutasteride 5fluciclovine F-18 3darolutamide 3Sodium Chloride 3Prednisone 3Magnetic Resonance Spectroscopy 3Flutamide 3Androgen Antagonists 3Abiraterone Acetate 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3cabazitaxel 2Propofol 2Prednisolone 2Lidocaine 2Gonadotropin-Releasing Hormone 2Finasteride 2Dexamethasone 2Desflurane 2Ciprofloxacin 2testosterone 17 beta-cypionate 1semaglutide 1polyethylene glycol 3350 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Prostatic Neoplasms × Magnetic Resonance Spectroscopy × Clear all
NCT06733350 2026-05-14

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Roswell Park Cancer Institute

Phase 4 Recruiting
600 enrolled
Genitourinary

Prostatic Neoplasms

NCT04134208 2025-01-16

An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer

M.D. Anderson Cancer Center

Phase 4 Terminated
2 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

NCT01230905 2017-04-24

AST

Ottawa Heart Institute Research Corporation

Phase 4 Completed
181 enrolled
Genitourinary

Coronary Artery Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡